keyword
https://read.qxmd.com/read/38787434/a-population-based-analysis-of-the-management-of-symptoms-of-depression-among-patients-with-stage-iv-non-small-cell-lung-cancer-nsclc-in-ontario-canada
#41
JOURNAL ARTICLE
Vivian S Tan, Michael C Tjong, Wing C Chan, Michael Yan, Victoria Delibasic, Gail Darling, Laura E Davis, Mark Doherty, Julie Hallet, Biniam Kidane, Alyson Mahar, Nicole Mittmann, Ambica Parmar, Hendrick Tan, Frances C Wright, Natalie G Coburn, Alexander V Louie
PURPOSE: Patients with lung cancer can experience significant psychological morbidities including depression. We characterize patterns and factors associated with interventions for symptoms of depression in stage IV non-small cell lung cancer (NSCLC). METHODS: We conducted a population-based cohort study using health services administrative data in Ontario, Canada of stage IV NSCLC diagnosed from January 2007 to September 2018. A positive symptom of depression score was defined by reporting at least one ESAS (Edmonton Symptom Assessment System) depression score ≥ 2 following diagnosis until the end of follow-up (September 2019)...
May 24, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38787191/radiotherapy-for-canine-apocrine-gland-anal-sac-adenocarcinoma-survival-outcomes-and-side-effects-of-a-palliative-treatment-protocol-of-20-gy-in-five-consecutive-fractions
#42
JOURNAL ARTICLE
Carlos Roberto Mendez Valenzuela, Kelly Shin, Hsin-Yi Weng, Jeannie M Plantenga, Isabelle F Vanhaezebrouck
This research aims to evaluate the outcomes of a radiotherapy protocol, consisting of five fractions of 4 Gy each, resulting in a total dose of 20 Gy for apocrine gland anal sac tumors and local lymph nodes in canines. This protocol was assessed as a palliative treatment for macroscopic tumors alone, or in combination with additional therapies under different scenarios. Medical records from fifty canine patients met the inclusion criteria and were divided into different treatment groups: radiotherapy alone (n = 22, 44%), radiotherapy with chemotherapy or targeted therapy with toceranib (n = 18, 36%), surgery with radiotherapy (n = 5, 10%), and surgery with radiotherapy and chemotherapy or targeted therapy with toceranib (n = 5, 10%)...
May 15, 2024: Veterinary Sciences
https://read.qxmd.com/read/38786969/management-of-ebstein-anomaly-in-the-current-era-the-story-of-one-fetus-and-the-collaboration-of-many-a-case-report
#43
Ann Kavanaugh-McHugh, Lisa C Zuckerwise, Stacy A S Killen, Emily A Morris, Rachel T Sullivan, Mhd Wael Alrifai, David P Bichell, Melissa Smith-Parrish, Lindsay Freud
Collaborative multicenter research has significantly increased our understanding of fetal Ebstein anomaly, delineating risk factors for adverse outcomes as well as predictors of postnatal management. These data are incorporated into prenatal care and therapeutic strategies and inform family counseling and delivery planning to optimize care. This report details the translation of findings from multicenter studies into multidisciplinary prenatal care for a fetus with Ebstein anomaly, supraventricular tachycardia, and a circular shunt, including transplacental therapy to control arrhythmias and achieve ductal constriction, informed and coordinated delivery room management, and planned univentricular surgical palliation...
May 9, 2024: Journal of Cardiovascular Development and Disease
https://read.qxmd.com/read/38785215/efficacy-and-safety-of-eribulin-mesylate-in-patients-with-locally-advanced-or-metastatic-breast-cancer-previously-treated-with-anthracycline-taxanes
#44
JOURNAL ARTICLE
Lan Chen, Xi Yan, Ting Luo, Tinglun Tian, Ping He, Xiaorong Zhong
BACKGROUND: This prospective real-world study aimed to assess the efficacy and safety of eribulin in the clinical practice against advanced breast cancer (ABC) in China. PATIENTS AND METHODS: In this study, eligible patients with inoperable locally advanced or metastatic breast cancer who had experienced prior neo-/adjuvant or failed the palliative treatment with anthracycline/taxanes were included. Eribulin (1.4 mg/m2 ) was infused intravenously on Day 1 and Day 8 every 3 weeks until disease progression or intolerable toxicity occurred...
May 2024: Cancer Medicine
https://read.qxmd.com/read/38785070/novel-approaches-in-the-medical-management-of-compensated-cirrhosis
#45
REVIEW
Antonio Moreno-Loro, Álvaro Giráldez, Fernando Jiménez, Ignacio López-Bueno, Alberto Pérez-Ramírez, Manuel Romero-Gómez
INTRODUCTION: Novel management of liver cirrhosis is supported by the well-established paradigm of liver cirrhosis as a dynamic, systemic, and reversible disease strongly related to the availability of etiological therapy. Classically, clinical practice guidelines and expert recommendations have focused on the management of decompensated cirrhotic patients, so we focused this review on improving care for compensated cirrhotic patients who are followed up in outpatient clinics. AREAS COVERED: We reviewed the current methods for establishing liver function, the diagnosis and management of advanced chronic liver disease and clinically significant portal hypertension as well as the prevention of its complications, with special attention to covert hepatic encephalopathy, we also paid attention to the extrahepatic complications of cirrhosis and the palliative care...
May 24, 2024: Expert Review of Gastroenterology & Hepatology
https://read.qxmd.com/read/38784787/interstitial-cystitis-an-imbalance-of-risk-and-protective-factors
#46
REVIEW
Jodi L Westropp, Judith L Stella, C A Tony Buffington
Interstitial cystitis (IC) presents as a chronic pain condition with variable combinations of symptoms depending on the species and individual patient. It is diagnosed by the presence of lower urinary tract signs and symptoms in combination with a variety of comorbid health problems, a history of life adversities, and the absence of other conditions that could cause the lower urinary tract signs. IC occurs naturally in humans and cats as a dimensional condition, with patients presenting with mild, moderate, and severe symptoms...
2024: Front Pain Res (Lausanne)
https://read.qxmd.com/read/38783256/real-world-efficacy-and-safety-of-capecitabine-with-oxaliplatin-in-patients-with-advanced-adenocarcinoma-of-the-ampulla-of-vater
#47
JOURNAL ARTICLE
Seunghwan Lee, Se Jun Park, Kabsoo Shin, Tae Ho Hong, In-Ho Kim, Myung Ah Lee
BACKGROUND: Adenocarcinoma of the ampulla of Vater (AoV) is one of the rare periampullary cancers, and due to its anatomical location, it is categorized into various histologic subtypes. Its rarity and diversity pose challenges in treatment decision-making for patients with advanced AoV carcinoma. This study investigated the efficacy and safety of the combined regimen of capecitabine and oxaliplatin (CAPOX) in a real-world clinical setting. METHODS: This investigation encompassed patients with advanced AoV carcinoma who underwent CAPOX treatment...
May 23, 2024: BMC Cancer
https://read.qxmd.com/read/38781541/multidisciplinary-standards-and-evolving-therapies-for-patients-with-pancreatic-cancer
#48
REVIEW
Rachael A Safyan, Eejung Kim, Emmelie Dekker, Marjolein Homs, Andrew J Aguirre, Bas Groot Koerkamp, E Gabriela Chiorean
Pancreatic ductal adenocarcinoma (PDA) is a challenging disease that presents at an advanced stage and results in many symptoms that negatively influence patients' quality of life and reduce their ability to receive effective treatment. Early implementation of expert multidisciplinary care with nutritional support, exercise, and palliative care for both early-stage and advanced disease promises to maintain or improve the patients' physical, social, and psychological well-being, decrease aggressive interventions at the end of life, and ultimately improve survival...
June 2024: American Society of Clinical Oncology Educational Book
https://read.qxmd.com/read/38780826/effectiveness-of-the-socioecological-informed-contextual-treatment-summary-and-care-plan-tsscp-p-brazil-for-breast-cancer-survivors-a-randomized-controlled-study
#49
RANDOMIZED CONTROLLED TRIAL
Maria das Graças Silva Matsubara, Cristiane Decat Bergerot, Kimlin Tam Ashing, Fabiana Baroni Alves Makdissi, Simone Elias, Edvane Birelo Lopes De Domenico
OBJECTIVE: This study aimed to evaluate the impact of an intervention using the Treatment Summary and Survivorship Care Plan (TSSCP-P) on self-efficacy and quality of life (QoL) in breast cancer survivors. METHOD: A clinical study, randomized and controlled, conducted to assess self-efficacy and QOL in breast cancer survivors. The participants were randomly assigned to either an intervention group or a control group. The intervention group received individualized nursing consultations guided by the TSSCP-P, while the control group received standard care...
May 23, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38780707/telehealth-cognitive-behaviour-therapy-for-the-management-of-sleep-disturbance-in-women-with-early-breast-cancer-receiving-chemotherapy-a-feasibility-study
#50
MULTICENTER STUDY
Emma-Kate Carson, Haryana M Dhillon, Janette L Vardy, Chris Brown, Kelly Ferrao Nunes-Zlotkowski, Stephen Della-Fiorentina, Sarah Khan, Andrew Parsonson, Felicia Roncoloato, Antonia Pearson, Tristan Barnes, Belinda E Kiely
PURPOSE: Sleep quality commonly deteriorates in people receiving chemotherapy for breast cancer (BC). We aimed to determine feasibility and acceptability of telehealth-delivered cognitive behaviour therapy for insomnia (CBT-I) in people with early BC receiving (neo)adjuvant chemotherapy. METHODS: Multi-centre, single arm, phase 2 feasibility trial. People with stage I-III BC received 4 sessions of telehealth CBT-I over 8 weeks, during chemotherapy. Participants completed Pittsburgh Sleep Quality Index (PSQI) and other Patient Reported Outcome Measures (PROMs) at baseline, post-program (week 9) and post-chemotherapy (week 24); and an Acceptability Questionnaire at week 9...
May 23, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38778925/non-targeted-effects-of-radiation-therapy-for-glioblastoma
#51
REVIEW
Lucie Lerouge, Aurélie Ruch, Julien Pierson, Noémie Thomas, Muriel Barberi-Heyob
Radiotherapy is recommended for the treatment of brain tumors such as glioblastoma (GBM) and brain metastases. Various curative and palliative scenarios suggest improved local-regional control. Although the underlying mechanisms are not yet clear, additional therapeutic effects have been described, including proximity and abscopal reactions at the treatment site. Clinical and preclinical data suggest that the immune system plays an essential role in regulating the non-targeted effects of radiotherapy for GBM...
May 30, 2024: Heliyon
https://read.qxmd.com/read/38778653/-radiation-therapy-in-veterinary-medicine-at-the-university-of-li%C3%A3-ge
#52
JOURNAL ARTICLE
Annick Hamaide, Jérôme Benoit
Radiation therapy has many indications in veterinary oncology and allows a multidisciplinary approach for the treatment of canine and feline patients. Radiation therapy can be recommended as a sole therapy in case of radiosensitive tumors or can be associated to surgery and/or chemotherapy after marginal excision for example. It can also be recommended as a palliative treatment for patients with an inoperable or painful tumor or disseminated disease. Radiation therapy significantly improves the quality of life and survival time of treated animals and should be part of the therapeutic modalities in veterinary medicine...
May 2024: Revue Médicale de Liège
https://read.qxmd.com/read/38778645/-stereotactic-radiation-therapy-for-liver-tumours
#53
REVIEW
Alexandre Taillez, Isaure Roquette
Liver lesions are common in oncology, and various focal treatments can be used, such as surgery, chemoembolization, radiofrequency, and systemic treatment. However, these treatments are often not feasible for a number of reasons, including the patient's general health or the characteristics of the lesion itself. Additionally, localized relapses may occur after focal treatments. In the past, liver radiotherapy was limited by the toxicities it caused and was mainly used in palliative situations or specific pre-transplant management...
May 2024: Revue Médicale de Liège
https://read.qxmd.com/read/38778642/-clinical-research-in-radiation-oncology
#54
REVIEW
Philippe Maingon
Clinical research is summarizing scientific trials performed in human aiming to improve biological and medical knowledges. The management of such an activity has to be conducted in a secured environment in terms of expertise, competency and professionalism of involved actors. In the field of cancer, multidisciplinarity is key in the treatment of malignant disease and plays a major role sequentially or concomitantly. In the 90s, clinical research in radiation oncology obtained historical successes, which remain validated guidelines for national societies in a significant number of clinical situations...
May 2024: Revue Médicale de Liège
https://read.qxmd.com/read/38777864/chemotherapy-induced-febrile-neutropenia-fn-healthcare-resource-utilization-hcru-and-costs-in-commercially-insured-patients-in-the-us
#55
JOURNAL ARTICLE
Jeanine A Flanigan, Marie Yasuda, Chi-Chang Chen, Edward C Li
PURPOSE: Febrile neutropenia (FN) is a known side effect of chemotherapy, often requiring hospitalization. Economic burden increases with an FN episode and estimates of cost per episode should be updated from real-world data. METHODS: A retrospective claims analysis of FN episodes in patients with non-myeloid malignancies from 2014 to 2021 was performed in IQVIA PharMetrics® Plus database. FN episodes were defined as having same-day claims for neutropenia and fever or infection, plus antibiotic in outpatient settings, following a claim for chemotherapy; index date was defined as the first claim for neutropenia/fever/infection...
May 23, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38776612/optimizing-care-in-early-phase-cancer-trials-the-role-of-palliative-care
#56
REVIEW
Fionnuala Crowley, Richard Sheppard, Stephanie Lehrman, Eve Easton, Thomas U Marron, Deborah Doroshow, Debora Afezolli
Advancements in cancer treatment have led to improved survival rates, with early phase clinical trials (EPCTs) serving as important initial steps in evaluating novel therapies. Recent studies have shown that response rates in these trials have doubled in the last twenty years. Patients who enroll on EPCTs have advanced cancer and heightened symptomatology yet maintain a robust performance status that qualifies them for clinical trial participation. It is well established that many of these patients have needs that can be addressed by palliative care, including symptom management, value assessments, advance care planning, and psychosocial and spiritual support...
May 19, 2024: Cancer Treatment Reviews
https://read.qxmd.com/read/38770684/dexmedetomidine-in-palliative-care-a-versatile-new-weapon-against-delirium-and-pain-systematic-review
#57
REVIEW
Teresa Tavares, Joana Almeida, Edna Gonçalves, Fernando Abelha
Introduction: At the end of life, the prevalence of delirium and pain is high. Current therapy is not satisfactory. Dexmedetomidine could be useful in the control of delirium and pain but is not approved outside of intensive care setting. Our objectives are to evaluate existing evidence in the literature that assessed the efficacy of dexmedetomidine in pain and delirium control and its safety in palliative care patients outside intensive care units. This systematic review was prospectively registered with PROSPERO and included a risk of bias assessment...
May 21, 2024: Journal of Palliative Medicine
https://read.qxmd.com/read/38770162/to-study-the-survival-outcomes-of-uncommon-recurrences-among-patients-with-cervical-cancer-compared-with-loco-regional-and-nodal-recurrences-at-a-tertiary-care-center-in-north-east-india-bridging-the-knowledge-gap-in-the-existing-literature
#58
JOURNAL ARTICLE
Mahendra Kumar, Upasana Baruah, Dimpy Begum, Debabrata Barmon, Jyotiman Nath, Duncan Khanikar, Karthik Chandra Bassetty
BACKGROUND: Recurrence rates of FIGO stage IB-IIA and IIB-IVA cervical cancer  28-64  respectively. There is a scarcity of data on the recurrence recurrence pattern for unusual sites and theirrecurrence pattern for unusual sites and its association with survival and prognosis. OBJECTIVE: To study overall survival in patients with distant metastasis compared to local and regional nodal metastasis. METHODS: A retrospective study was done from 1/1/2017 to 30/12/22...
June 2024: European journal of obstetrics & gynecology and reproductive biology: X
https://read.qxmd.com/read/38770109/hiv-related-stigma-among-pregnant-adolescents-a-qualitative-study-of-patient-perspectives-in-southwestern-uganda
#59
JOURNAL ARTICLE
Amir Kabunga, Caroline Kambugu Nabasirye, Eustes Kigingo, Halimah Namata, Enos Mwirotsi Shikanga, Samson Udho, Anna Grace Auma, Jannat Nabaziwa, Raymond Tumwesigye, Marvin Musinguzi, Ponsiano Okalo, Walter Acup
BACKGROUND: The HIV epidemic disproportionately affects adolescents in Sub-Saharan Africa, with adolescent girls facing heightened vulnerability. Despite advancements in antiretroviral therapy, HIV-related stigma remains prevalent, particularly among pregnant adolescents. This qualitative study explores the perspectives of adolescents living with HIV in southwestern Uganda, seeking to understand the nature of HIV-related stigma in this context. METHODS: One-on-one narrative interviews were conducted with 28 pregnant adolescents living with HIV aged 14-19 receiving care at Mbarara Regional Referral Hospital...
2024: HIV/AIDS: Research and Palliative Care
https://read.qxmd.com/read/38769799/palliative-care-in-kidney-transplant-recipients-with-graft-failure
#60
JOURNAL ARTICLE
Maggie Kam-Man Ma, Desmond Yat-Hin Yap, Kwok-Ying Chan, Tak Mao Chan
Kidney transplantation is the best renal replacement therapy for patients with end stage kidney disease. It provides longer patient survival and better quality of life than dialysis. The clinical course after kidney transplantation could be complex and variable. Patients may develop various complications or even kidney graft failure. Symptom burden related to uraemia in patients with graft failure, and the side-effects of immunosuppression, cause psychological distress and adversely affect the quality of life of patients...
May 14, 2024: Annals of Palliative Medicine
keyword
keyword
88971
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.